Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2007
07/03/2007CA2367131C Methods for fine powder formation
07/03/2007CA2364510C Method of using emamectin to treat fish parasites
07/03/2007CA2350884C Topical compositions comprising ascomycins
07/03/2007CA2328945C Softgel-compatible composition containing retinol
07/03/2007CA2319096C Method for treating acute intermittent porphyria (aip) and other porphyric diseases
07/03/2007CA2297153C Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
07/03/2007CA2278798C Aminobenzophenones as inhibitors of interleukin and tnf
07/03/2007CA2266048C Topical composition and method for enhancing lipid barrier synthesis
07/03/2007CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
07/03/2007CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
07/03/2007CA2244662C Antifungal agents
07/03/2007CA2174122C Therapeutic delivery compositions and methods of use thereof
07/03/2007CA2168021C Vasoconstrictive dihydrobenzopyran derivatives
07/03/2007CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy
07/03/2007CA2156162C Cancer treatment
07/03/2007CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
07/03/2007CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds
07/03/2007CA2108192C Use of tyloxapol as a nanoparticle stabilizer and dispersant
06/2007
06/29/2007CA2572057A1 A photoactive biocompatible coating composition
06/28/2007WO2007073555A1 Use of 4, 7-dihydrothieno [2, 3-b] pyridine compounds in the treatment of cardiovascular diseases
06/28/2007WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
06/28/2007WO2007073424A1 Pure rocuronium bromide
06/28/2007WO2007073407A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
06/28/2007WO2007073405A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/28/2007WO2007073397A1 Kits and improved compositions for treating lower urinary tract discorders
06/28/2007WO2007073389A1 Compressed solid dosage forms with drugs of low solubility and process for making the same
06/28/2007WO2007073325A1 Method and composition for treating and diagnosing restless legs syndrome
06/28/2007WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
06/28/2007WO2007073301A1 Benzoimidazole derivatives as prodrugs of proton pump inhibitors
06/28/2007WO2007073300A1 Gaba-b receptor modulators
06/28/2007WO2007073299A1 Imidazoles as gaba-b receptor modulators
06/28/2007WO2007073298A1 Imidazole derivatives for the treatment of gastrointestinal disorders
06/28/2007WO2007073297A1 Pyrazoles for the treatment of gerd and ibs
06/28/2007WO2007073296A1 Heterocyclic gaba-b modulators
06/28/2007WO2007073284A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES
06/28/2007WO2007073283A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
06/28/2007WO2007073231A1 Agent for treating tumoral diseases, a method for the production thereof and a method for treating tumoral diseases
06/28/2007WO2007073187A1 Carbohydrate composition for flat glucose response
06/28/2007WO2007073168A1 Carbamate antibiotics
06/28/2007WO2007073136A1 Pharmaceutical compositions containing derivative substances of thiazolidinediones combined with a biguanide for use in type 2 diabetes mellitus
06/28/2007WO2007073135A1 Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause
06/28/2007WO2007073134A1 Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight
06/28/2007WO2007073133A1 Pharmaceutical compositions containing substances that inhibit the reuptake of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight
06/28/2007WO2007073132A1 Pharmaceutical compositions containing calcium antagonist substances combined with platelet aggregation inhibiting agents for use in systemic arterial hypertension and for the prevention of ischemic vascular events
06/28/2007WO2007073131A1 Pharmaceutical compositions containing combined platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events
06/28/2007WO2007073112A1 A composition comprising azole antifungal drug and a preparation process thereof
06/28/2007WO2007073096A1 Anti-gastritis and anti-ulcer agent containing momordicae semen extract and momordica saponin i isolated from the same
06/28/2007WO2007073006A1 Inducer for increasing of content of cytoprotective amino acid and method for increasing the content
06/28/2007WO2007072992A2 Solid preparation containing an insulin sensitizer
06/28/2007WO2007072974A1 P2x4 receptor antagonist
06/28/2007WO2007072965A1 Angiogenesis inhibitor and utilization of the same
06/28/2007WO2007072923A1 Preparation for external use having improved temporal stability of steroid
06/28/2007WO2007072911A1 Preparation with improved bioabsorbability of sapropterin hydrochloride
06/28/2007WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME
06/28/2007WO2007072908A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
06/28/2007WO2007072902A1 Therapeutic agent for acute cerebral infarct
06/28/2007WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound
06/28/2007WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv)
06/28/2007WO2007072851A1 Process for production of water-soluble azole prodrug
06/28/2007WO2007072845A1 Therapeutic agent or therapeutic method for ischemic stroke
06/28/2007WO2007072840A1 Orally disintegrating tablet comprising fat-soluble substance
06/28/2007WO2007072800A1 Photosensitizing compound
06/28/2007WO2007072782A1 Carboxylic acid derivative or salt thereof
06/28/2007WO2007072764A1 Ce forming/maturing agent, parakeratosis inhibitor, skin barrier function recovery accelerator, and skincare composition for external application to skin
06/28/2007WO2007072756A1 Mineral absorption enhancer, food and feeding stuff
06/28/2007WO2007072749A1 Antitussive agent
06/28/2007WO2007072564A1 Remedy/preventive for heart failure
06/28/2007WO2007072503A2 Combinations for managing inflammation and associated disorders
06/28/2007WO2007072495A2 Coated tablets having prolonged gastric retention
06/28/2007WO2007072476A2 Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of aripiprazole
06/28/2007WO2007072179A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents
06/28/2007WO2007072178A1 Novel proline-derivative based cosmetological and/or dermatological compositions and uses thereof
06/28/2007WO2007072169A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
06/28/2007WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth
06/28/2007WO2007072156A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor
06/28/2007WO2007072151A1 8-pyrazinyl-s-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents
06/28/2007WO2007072150A2 Piperidine derivatives
06/28/2007WO2007072146A1 Chromane substituted benzimidazoles and their use as acid pump inhibitors
06/28/2007WO2007072095A1 New compounds
06/28/2007WO2007072094A1 New compounds
06/28/2007WO2007072093A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
06/28/2007WO2007072092A2 New phenanthridine derivatives as bradykinin antagonists
06/28/2007WO2007072091A1 New compounds
06/28/2007WO2007072090A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives
06/28/2007WO2007072083A1 Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione
06/28/2007WO2007072080A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
06/28/2007WO2007072041A1 Therapeutic compounds
06/28/2007WO2007071992A1 Casein-like secreted protein
06/28/2007WO2007071970A2 Combination of azd2171 and pemetrexed
06/28/2007WO2007071967A2 Substituted phenol derivatives as analgesics
06/28/2007WO2007071966A1 Pyrimido- [4, 5-b] -oxazines for use as dgat inhibitors
06/28/2007WO2007071965A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
06/28/2007WO2007071961A1 Benzamide derivatives
06/28/2007WO2007071958A2 Combination of zd6474 and pemetrexed
06/28/2007WO2007071956A1 Novel benzamide derivatives
06/28/2007WO2007071955A1 Chemical compounds
06/28/2007WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
06/28/2007WO2007071951A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
1 ... 3688 3689 3690 3691 3692 3693 3694 3695 3696 3697 3698 3699 3700 3701 3702 3703 3704 3705 3706 3707 3708 ... 7860